Agilent Technologies
Agilent Technologies, Inc. is a prominent provider of laboratory solutions focused on the life sciences, diagnostics, and applied chemical markets globally. The company operates through three main segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. It offers a wide range of instruments and technologies, including chromatography systems, mass spectrometry, spectroscopy, and cell analysis tools, aimed at enhancing laboratory efficiency and data management. Agilent also specializes in genomic analysis, providing tools for DNA mutation detection, gene expression profiling, and quality control of nucleic acid samples. Furthermore, the Agilent CrossLab segment delivers consumables, training, and consultation services to support laboratory operations. The company markets its products via direct sales, distributors, and electronic commerce, serving diverse sectors such as biopharmaceuticals, environmental testing, forensics, and food safety. Founded in 1999 and headquartered in Santa Clara, California, Agilent Technologies continues to innovate and collaborate with various organizations to address critical scientific needs.
Top Stages
86 past transactions
Sigsense Technologies
Acquisition in 2024
Sigsense Technologies, Inc. is a technology company based in San Francisco, California, that specializes in developing equipment monitoring software solutions. Established in 2013, Sigsense has created a proprietary artificial intelligence platform designed to provide a comprehensive, vendor-agnostic management solution for equipment operations across various industries. The platform utilizes real-time data gathered from non-invasive power and environmental IoT sensors to deliver insights into machine performance, enabling predictive maintenance and identifying opportunities for process optimization. By tracking context-rich data, the software helps clients detect operational issues before they lead to failure, thereby minimizing downtime and enhancing productivity. Sigsense Technologies aims to empower service organizations, asset owners, and manufacturers to maximize the efficiency of their equipment and maintain a competitive edge in their respective markets.
RareCyte
Venture Round in 2024
RareCyte, Inc. is a life sciences company based in Seattle, Washington, founded in 2009. The company specializes in developing advanced platforms for liquid and tissue biopsy analysis, focusing on the detection and characterization of rare cells, particularly circulating tumor cells (CTCs) and circulating endothelial cells (CECs) in blood samples. RareCyte's AccuCyte system provides an open platform that facilitates the unbiased discovery and isolation of these rare cells, supporting various applications in cancer research, cardiovascular disease studies, and diagnostic development. The company offers a range of products, including sample preparation systems, staining kits, automated fluorescence microscopy instruments, and slide imaging systems. By enabling precision medicine approaches, RareCyte aims to provide new tools for medical professionals and researchers to address complex questions in the fields of cancer and other therapeutic areas.
Elegen
Series B in 2024
Elegen is a biotechnology company founded in 2017 and led by Dr. Matthew Hill, specializing in the development of microfluidic technology. The company focuses on creating innovative DNA synthesizers that enhance the engineering of entire genomes. By leveraging its advanced technology, Elegen aims to accelerate biomedical advancements and facilitate DNA sequence testing within the healthcare industry. Through its commitment to disrupting synthetic biology, Elegen is positioned to play a pivotal role in the future of genetic research and applications.
Biofidelity
Venture Round in 2024
Biofidelity Ltd., established in 2019 and based in Cambridge, UK, specializes in the research and development of molecular diagnostic assays. These assays are designed to rapidly detect specific DNA sequences, with a focus on applications in oncology, prenatal testing, infectious diseases, and organ transplant monitoring. The company's mission is to enhance and prolong patients' lives through early disease detection and targeted treatments.
Halo X Ray Technologies
Series A in 2023
HALO X-ray Technologies has been spun out of the Imaging Science Group at Nottingham Trent University and the Cranfield Forensic Institute at Cranfield University. We are developing commercially-focused OEM X-ray diffraction solutions based on novel and patented Focal Construct Technology that provides platform capability across a wide range of application areas. Their initial focus lies in the development of HALO solutions for the aviation security and the medical systems markets. We have strong ties to the aviation sector through a long and prestigious research and development programme that has previously realised novel divergent beam X-ray technology (developed and marketed through various incumbent suppliers such as 3DX-ray Ltd) and kinetic depth systems (developed and marketed through Astrophyscis Inc) as 3rd party solutions. We have a clear focus on medical systems and we are currently part of a consortium recentlly awarded an EPSRC grant on Point-of-Care High Accuracy Fracture Risk Prediction. This is an exciting project and we look forward to working with our partners in developing HALO technology for this market.
e-MSion
Acquisition in 2023
e-MSion is a biotechnology research service provider focused on advancing mass spectrometry-based life sciences research. The company specializes in enhancing protein mass spectrometry through its innovative compact add-on device, which enables electron capture dissociation (ECD) fragmentation in benchtop mass spectrometers for the first time. This technology aims to improve the analysis and understanding of complex biological samples, thereby facilitating significant advancements in the field of proteomics. By making ECD fragmentation accessible, e-MSion seeks to support researchers in their quest to explore and manipulate biological molecules with greater precision.
Avida Biomed
Acquisition in 2023
Avida Biomed aims to advance molecular diagnostics through genomic tool innovation and integration.
PSS polymer standards service
Acquisition in 2022
PSS polymer standards service under develops and manufactures. They offer techniques and instrumentation for the characterization, production, optimization of synthetic, natural, and bio-polymers. Company is a perfect separation solutions for polymers, biopolymers, polysaccharides, and proteins.
Halo Labs
Series C in 2022
Halo Labs is a life science instrumentation company based in Burlingame, California, specializing in the development of tools for biologics researchers. Formerly known as Optofluidics, the company focuses on high throughput biopharmaceutical quality control, utilizing advanced optics, image processing, and microfluidics technologies. Halo Labs' offerings include assessment of biologics-developability, formulation development, late-stage formulation, small molecule solubility, and AAV analytics. Founded in 2011, the company has gained recognition for its innovative scientific platform, which provides critical insights into the particles involved in research processes, thereby enhancing the stability and quality assessment of biological drugs.
Arima Genomics
Series B in 2022
Arima Genomics, Inc. is a biotechnology company based in San Diego, California, that specializes in developing innovative solutions for genome sequencing and structural analysis, with a focus on human health, disease, and species evolution. The company offers the Arima-HiC proximity ligation kit, which captures the three-dimensional organization of chromatin, allowing researchers to understand the spatial relationships of genomic sequences. Additionally, Arima Genomics provides The Arima-HiChIP protocol, a streamlined method for identifying long-range genomic interactions facilitated by proteins, combining Hi-C technology with chromatin immunoprecipitation. These technologies enable various genomic applications, such as identifying promoter-enhancer interactions and scaffolding contigs for genome assemblies. Founded in 2015, Arima Genomics aims to accelerate genomic discovery and improve understanding of the genome's role in health and disease.
Molecular Assemblies
Series B in 2022
Molecular Assemblies, Inc. is a San Diego-based company that specializes in enzymatic DNA synthesis technology, aimed at creating DNA-based products across various industries. Founded in 2013, the company has developed a proprietary method that allows for the reliable, affordable, and sustainable production of long, high-quality, sequence-specific DNA. This innovative technology is designed to support advancements in industrial synthetic biology, personalized therapeutics, precision diagnostics, and has potential applications in information storage and nanotechnology. With a strong executive and scientific team, as well as a robust intellectual property portfolio, Molecular Assemblies is positioned to enhance the capabilities of researchers and contribute to the evolution of DNA-based applications.
PreciseDx
Series A in 2022
PreciseDx is a specialized company focused on cancer risk stratification, providing patient-specific risk assessments through the analysis of morphological features. By leveraging artificial intelligence and its proprietary Morphology Feature Array™, PreciseDx develops disease-specific assays that enhance the understanding of a patient's risk profile and potential outcomes. This innovative approach allows clinical teams to gain valuable insights and actionable intelligence, facilitating more personalized treatment decisions. The company's expertise spans clinical modeling, patient phenotyping, image analysis, and the application of big data in real-world scenarios, ultimately aiming to improve patient outcomes and quality of life in cancer care and other diseases.
Nicoya Lifesciences
Series A in 2021
Nicoya Lifesciences Inc. is a Canadian company based in Kitchener that specializes in developing advanced sensor products for the biotechnology and pharmaceutical industries. Founded in 2012, Nicoya creates instruments designed to analyze biomolecular interactions, including proteins, antibodies, DNA, RNA, and small molecules. Their product lineup includes surface plasmon resonance (SPR) instruments, spectrophotometers, sensor chips, reagents, and accessories, as well as the OpenSPR, a personal label-free biomolecular analysis instrument. In addition to hardware, Nicoya offers software solutions for real-time kinetic analysis, instrument control, and optical peak tracking, enhancing the capabilities of their analytical tools.
Akadeum
Series B in 2021
Akadeum Life Sciences, Inc. is a life sciences company based in Ann Arbor, Michigan, specializing in the manufacturing of microbubble cell separation products. Founded in 2014, the company develops bioseparation products that utilize microscopic microbubbles to efficiently capture and isolate target cells from biological samples. Their offerings include T cell and B cell isolation kits for both human and mouse cells, as well as depletion microbubbles for red blood cell separation. Akadeum's products streamline the process of removing specific cells, such as bacteria or viruses, from liquid samples, thereby enhancing the efficiency of downstream testing and analysis. The company also collaborates with strategic partners, including Agilent Technologies, to further advance its innovative solutions in cell separation. Akadeum Life Sciences sells its products online, aiming to improve cell-based research and diagnostics in the life sciences sector.
RareCyte
Series G in 2021
RareCyte, Inc. is a life sciences company based in Seattle, Washington, founded in 2009. The company specializes in developing advanced platforms for liquid and tissue biopsy analysis, focusing on the detection and characterization of rare cells, particularly circulating tumor cells (CTCs) and circulating endothelial cells (CECs) in blood samples. RareCyte's AccuCyte system provides an open platform that facilitates the unbiased discovery and isolation of these rare cells, supporting various applications in cancer research, cardiovascular disease studies, and diagnostic development. The company offers a range of products, including sample preparation systems, staining kits, automated fluorescence microscopy instruments, and slide imaging systems. By enabling precision medicine approaches, RareCyte aims to provide new tools for medical professionals and researchers to address complex questions in the fields of cancer and other therapeutic areas.
MOBILion Systems
Series C in 2021
MOBILion Systems, Inc. is a biotechnology company based in Chadds Ford, Pennsylvania, focused on developing advanced analytical instrumentation for the detection and analysis of clinically relevant molecules. The company specializes in structures for lossless ion manipulation (SLIM), which facilitate ion mobility separations with high sensitivity and resolution. This technology allows researchers to identify and analyze challenging biomolecules, including proteins, peptides, metabolites, glycans, and lipids, that traditional instruments often fail to detect. By improving the accuracy of diagnostic tests and enabling earlier disease detection, MOBILion's innovations support the development of better therapeutics and enhance the ability to monitor and treat medical conditions effectively. Since its incorporation in 2015, MOBILion Systems has aimed to transform disease prediction, diagnosis, and treatment through its state-of-the-art technology.
Molecular Assemblies
Series A in 2021
Molecular Assemblies, Inc. is a San Diego-based company that specializes in enzymatic DNA synthesis technology, aimed at creating DNA-based products across various industries. Founded in 2013, the company has developed a proprietary method that allows for the reliable, affordable, and sustainable production of long, high-quality, sequence-specific DNA. This innovative technology is designed to support advancements in industrial synthetic biology, personalized therapeutics, precision diagnostics, and has potential applications in information storage and nanotechnology. With a strong executive and scientific team, as well as a robust intellectual property portfolio, Molecular Assemblies is positioned to enhance the capabilities of researchers and contribute to the evolution of DNA-based applications.
Resolution Bioscience
Acquisition in 2021
Resolution Bioscience is a leading innovator in cancer diagnostics, specializing in next-generation technologies that utilize liquid biopsies to enhance treatment personalization for patients. The company’s proprietary molecular analytics platform analyzes cell-free DNA, providing actionable insights that traditionally required invasive biopsy procedures. With a portfolio of over 50 focused panels, Resolution Bioscience is advancing companion diagnostics to facilitate therapeutic approvals. Their suite of clinical tests is designed to guide the selection of targeted therapies and monitor their effectiveness over time, ultimately aiming to improve cancer outcomes for patients. Through its development of novel biochemistry and bioinformatics technologies, Resolution Bioscience enhances the capabilities of DNA sequencing platforms, allowing for real-time monitoring of therapy responses and tailoring treatments to individual patient needs.
Cardea Bio
Series A in 2020
Cardea Bio, Inc. is a biotechnology company based in San Diego, California, focused on developing and commercializing bioelectronics for research and diagnostics. Established in 2013, Cardea utilizes proprietary graphene-based digital biosensors to create advanced biosensor hardware, software, and molecular infrastructure, enabling precision healthcare through improved diagnostic capabilities. The company's product offerings include the AGILE R100, an innovative assay for drug discovery, and the AGILE R200, an automated high-throughput screening solution. Cardea's biosensors convert biomolecular interactions into digital data, allowing for real-time biological signal analysis and access to streaming multi-omics data. Their solutions cater to various applications in life sciences and healthcare, such as small molecule validation, antibody characterization, and biomolecular analysis.
MOBILion Systems
Series B in 2020
MOBILion Systems, Inc. is a biotechnology company based in Chadds Ford, Pennsylvania, focused on developing advanced analytical instrumentation for the detection and analysis of clinically relevant molecules. The company specializes in structures for lossless ion manipulation (SLIM), which facilitate ion mobility separations with high sensitivity and resolution. This technology allows researchers to identify and analyze challenging biomolecules, including proteins, peptides, metabolites, glycans, and lipids, that traditional instruments often fail to detect. By improving the accuracy of diagnostic tests and enabling earlier disease detection, MOBILion's innovations support the development of better therapeutics and enhance the ability to monitor and treat medical conditions effectively. Since its incorporation in 2015, MOBILion Systems has aimed to transform disease prediction, diagnosis, and treatment through its state-of-the-art technology.
DNA Script
Series B in 2020
DNA Script is a pioneering company in the field of DNA synthesis, focused on enhancing life sciences and human health through innovative technology. It has developed the SYNTAX, the world's first benchtop DNA printer, which allows laboratories to produce synthetic oligonucleotides using a novel enzymatic process. This method employs natural enzymes for nucleic acid synthesis, enabling rapid and efficient production of critical genomic experimental precursors. By providing greater control over workflow and accelerating access to results, DNA Script supports researchers in advancing experiments and developing new therapeutics effectively.
Arima Genomics
Series A in 2020
Arima Genomics, Inc. is a biotechnology company based in San Diego, California, that specializes in developing innovative solutions for genome sequencing and structural analysis, with a focus on human health, disease, and species evolution. The company offers the Arima-HiC proximity ligation kit, which captures the three-dimensional organization of chromatin, allowing researchers to understand the spatial relationships of genomic sequences. Additionally, Arima Genomics provides The Arima-HiChIP protocol, a streamlined method for identifying long-range genomic interactions facilitated by proteins, combining Hi-C technology with chromatin immunoprecipitation. These technologies enable various genomic applications, such as identifying promoter-enhancer interactions and scaffolding contigs for genome assemblies. Founded in 2015, Arima Genomics aims to accelerate genomic discovery and improve understanding of the genome's role in health and disease.
MOBILion Systems
Series A in 2019
MOBILion Systems, Inc. is a biotechnology company based in Chadds Ford, Pennsylvania, focused on developing advanced analytical instrumentation for the detection and analysis of clinically relevant molecules. The company specializes in structures for lossless ion manipulation (SLIM), which facilitate ion mobility separations with high sensitivity and resolution. This technology allows researchers to identify and analyze challenging biomolecules, including proteins, peptides, metabolites, glycans, and lipids, that traditional instruments often fail to detect. By improving the accuracy of diagnostic tests and enabling earlier disease detection, MOBILion's innovations support the development of better therapeutics and enhance the ability to monitor and treat medical conditions effectively. Since its incorporation in 2015, MOBILion Systems has aimed to transform disease prediction, diagnosis, and treatment through its state-of-the-art technology.
Molecular Assemblies
Series A in 2019
Molecular Assemblies, Inc. is a San Diego-based company that specializes in enzymatic DNA synthesis technology, aimed at creating DNA-based products across various industries. Founded in 2013, the company has developed a proprietary method that allows for the reliable, affordable, and sustainable production of long, high-quality, sequence-specific DNA. This innovative technology is designed to support advancements in industrial synthetic biology, personalized therapeutics, precision diagnostics, and has potential applications in information storage and nanotechnology. With a strong executive and scientific team, as well as a robust intellectual property portfolio, Molecular Assemblies is positioned to enhance the capabilities of researchers and contribute to the evolution of DNA-based applications.
BioTek Instruments
Acquisition in 2019
BioTek Instruments, Inc. is a manufacturer and developer of advanced life science instrumentation and software, headquartered in Winooski, Vermont, with additional offices in countries such as China, Canada, and the United Kingdom. Founded in 1968 and currently a subsidiary of Agilent Technologies, the company specializes in microplate instrumentation, including multi-mode detection systems, imaging and microscopy equipment, liquid handling tools, and robotic automation. Its product offerings encompass cell imaging systems, microplate readers, washers, dispensers, and automated pipetting systems, all designed to facilitate research in healthcare, pharmaceuticals, agriculture, and other scientific fields. BioTek also provides Gen5, a comprehensive data analysis software, alongside various accessories and application support services. With a commitment to innovative solutions, BioTek Instruments aims to streamline workflows and enhance the efficiency of biomolecular analysis and cellular research.
Purigen Biosystems
Series B in 2019
Purigen Biosystems, Inc. is a biotechnology company based in Pleasanton, California, specializing in the extraction and purification of nucleic acids from biological samples. Founded in 2012, the company has developed an innovative ionic purification system that employs isotachophoresis, a technique that allows for the efficient separation and quantification of DNA and RNA without the need for physical surface binding. This technology is particularly advantageous for challenging sample types, such as formalin-fixed paraffin-embedded (FFPE) tissues and samples with low cell counts. Purigen's automated platform simplifies the processes of nucleic acid extraction, enrichment, and quantitation, providing researchers with fast and reliable results suitable for applications in qPCR, microarray, and next-generation sequencing (NGS). The company operates as a subsidiary of Agilent Technologies, Inc.
Mission Bio
Series B in 2018
Mission Bio, Inc. is a biotechnology company focused on advancing the study of cellular heterogeneity through its innovative Tapestri Platform, which is the first single-cell multi-omics platform. This platform allows for the simultaneous analysis of genotype and phenotype from individual cells, enabling precise detection of variations in disease progression and treatment responses. Utilizing proprietary microfluidic droplet technology, Mission Bio provides targeted solutions for high-impact applications in fields such as oncology, hematology, and genome editing. The company also offers Tapestri Designer, a cloud-based tool for creating custom single-cell DNA panels, enhancing its capabilities in research and clinical settings. Founded in 2011 and based in South San Francisco, California, Mission Bio was previously known as Torrent Bio, Inc. before rebranding in 2013.
ACEA Biosciences
Acquisition in 2018
ACEA Biosciences, Inc., established in 2002 and headquartered in San Diego, California, specializes in developing and commercializing microelectronic sensor systems for cell-based assays, drug discovery, and diagnostics. The company's flagship product, the x-CELLigence System, offers real-time, label-free cell analysis, serving diverse applications such as cell proliferation, cytotoxicity testing, and receptor function monitoring. ACEA's products cater to science research and drug discovery markets, with over 800 customers worldwide and numerous peer-reviewed publications. The company operates a state-of-the-art manufacturing facility in Hangzhou, China, and serves its global customer base as a subsidiary of Agilent Technologies, Inc.
ProZyme
Acquisition in 2018
ProZyme, Inc. is a specialized company that develops and manufactures proteins and enzymes tailored for diagnostics and research applications. Founded in 1990 and based in Hayward, California, ProZyme offers a range of biochemical reagents and supplies focused on carbohydrate analysis. Its product portfolio includes Glyko tools for glycobiology, purification and conjugation kits, and various reagents for glycoanalysis sample preparation, such as GlykoScreen and GlykoPrep. These solutions cater to the needs of pharmaceutical bioprocessing and drug discovery, supporting both large and small biotechnology and biopharmaceutical institutions. The company employs advanced technologies, including microbial fermentation and large-scale purification techniques, alongside analytical methods like HPLC and ELISAs, to enhance analytical results. ProZyme operates as a subsidiary of Agilent Technologies, Inc. as of July 2018.
Ultra Scientific
Acquisition in 2018
Ultra Scientific, based in North Kingstown, Rhode Island, is a global leader in the production of certified reference materials and laboratory solutions. It caters to diverse industries such as environmental, pharmaceutical, biotechnology, life science, and molecular testing laboratories, providing an extensive range of products including organic and inorganic standards, calibration standards, IQ/OQ/PQ checks, and quality control materials. Known for its rapid turnaround capabilities, Ultra Scientific enables various sectors, including academia and government, to meet their specific analytical needs efficiently.
Genohm
Acquisition in 2018
Genohm SA is a Swiss company that specializes in developing cloud-based software solutions for laboratory management. Founded in 2002 and headquartered in Lausanne, the company offers a comprehensive platform known as SLims, which integrates laboratory information management system (LIMS) functionalities with electronic laboratory notebook (ELN) features and order management capabilities. Genohm's software is designed to enable researchers and scientists to customize their digital data management systems according to their unique laboratory workflows. The company serves a diverse clientele, including biobanks, research and development laboratories, next-generation sequencing laboratories in universities and hospitals, as well as biotechnology firms. As of 2018, Genohm operates as a subsidiary of Agilent Technologies, Inc.
LaserGen
Acquisition in 2018
LaserGen, Inc. is a biotechnology company based in Houston, Texas, established in 2002. The company specializes in the development and commercialization of advanced technologies for genomics applications, particularly in next-generation sequencing and histology. LaserGen's solutions include nucleotides and tools that facilitate the detection of heritable and somatic sequence variations in the human genome, which are essential for diagnostic purposes in disease management. By providing innovative and cost-effective sequencing platforms, LaserGen enables scientists to enhance their capabilities in nucleotide chemistry and genomics. As of May 2018, LaserGen operates as a subsidiary of Agilent Technologies, Inc.
Advanced Analytical Technologies
Acquisition in 2018
Advanced Analytical Technologies, Inc. is a manufacturer and developer of high-throughput, fully-automated nucleic acid and genetic analysis systems, serving customers primarily in the United States and Germany. The company’s product offerings include the Fragment Analyzer for DNA and RNA quality control, the Zero Agarose Gel DNA Analyzer for automated DNA fragment analysis, Oligo PRO for assessing the purity of DNA and RNA oligonucleotides, and pKa PRO for measuring acid dissociation constants of various compounds. These instruments utilize capillary electrophoresis technology and are designed to enhance workflows in molecular diagnostics, pharmaceuticals, life sciences, agriculture, and biofuels. In addition to its products, Advanced Analytical Technologies provides installation, training, warranty, and technical support services through an established network of distributors and support centers. Founded in 1997, the company is headquartered in Ames, Iowa, with a laboratory and sales office located in Heidelberg, Germany.
Luxcel Biosciensces
Acquisition in 2018
Luxcel Biosciences Ltd., founded in 2002 and based in Cork, Ireland, specializes in porphyrin-based, phosphorescent oxygen-sensing probes and sensors. The company primarily serves the pharmaceutical, food safety, and packaging industries, providing a range of products including oxygen and pH sensors, as well as assays for mitochondrial function, metabolism, and toxicity. Notable offerings include the MitoXpress–Xtra assay for measuring oxygen consumption, the pH-Xtra assay for monitoring extracellular acidification, and the MitoXpress-Intra assay for assessing cell oxygenation. Luxcel also offers the OpTech system for non-invasive package integrity and shelf-life studies, alongside rapid microbial tests for bacterial detection. The company's tools are utilized in diverse applications such as cell analysis, hepatotoxicity, and food safety testing. Luxcel Biosciences sells its products directly and through authorized distributors, catering to pharmaceutical companies, processed food manufacturers, biotechnology firms, university labs, and research institutes.
NanoCellect Biomedical
Series B in 2017
NanoCellect Biomedical, Inc., established in 2009 and headquartered in San Diego, California, specializes in developing innovative flow cytometry and cell sorting solutions for life science researchers. The company's flagship product, the WOLF Cell Sorter, employs a unique closed fluid-path microfluidic cartridge to facilitate efficient cell sorting while mitigating biohazard risks and shear stress issues common in traditional methods. Their portfolio of affordable, compact, and user-friendly instruments and consumables caters to various applications such as drug discovery, single-cell omics, cloning, antibody discovery, and basic research, empowering biomedical scientists with simplified cellular analysis and sorting capabilities.
Agilent Raman Spectroscopy
Acquisition in 2017
Agilent Raman Spectroscopy’s proprietary technologies use novel variants of Raman spectroscopy. Their instruments can rapidly and accurately identify materials hidden inside objects or through opaque barriers such as plastic, coloured glass, paper and skin, or can measure the concentrations of materials in mixtures, with a high degree of accuracy. Agilent Raman Spectroscopy is formerly known as Cobalt Light Systems and is part of Agilent.
Multiplicom
Acquisition in 2016
Multiplicom is a company that specializes in the development of molecular diagnostics products specifically tailored for medical genetics. It manufactures molecular diagnostic kits that facilitate the collection of genetic information, allowing for early identification of congenital defects during pregnancy. By focusing on effective, affordable, and personalized medicine, Multiplicom aims to enhance patient care through advanced clinical laboratory-based tests. Its products are designed to empower healthcare providers and patients with critical genetic insights, contributing to more informed treatment decisions.
Molecular Assemblies
Seed Round in 2016
Molecular Assemblies, Inc. is a San Diego-based company that specializes in enzymatic DNA synthesis technology, aimed at creating DNA-based products across various industries. Founded in 2013, the company has developed a proprietary method that allows for the reliable, affordable, and sustainable production of long, high-quality, sequence-specific DNA. This innovative technology is designed to support advancements in industrial synthetic biology, personalized therapeutics, precision diagnostics, and has potential applications in information storage and nanotechnology. With a strong executive and scientific team, as well as a robust intellectual property portfolio, Molecular Assemblies is positioned to enhance the capabilities of researchers and contribute to the evolution of DNA-based applications.
iLab Solutions
Acquisition in 2016
iLab Solutions specializes in web-based management services tailored for academic research institutions, including leading universities and research hospitals. The company offers a comprehensive suite of tools designed to facilitate laboratory management, encompassing core facility service request management, sample management, equipment reservation and usage tracking, billing and invoicing, and lab requisitioning. iLab's services are backed by a scientific advisory team of active principal investigators from prestigious institutions, enhancing the relevance and effectiveness of its solutions. The leadership team consists of professionals with extensive experience across various sectors, including research, consulting, and technology. iLab emphasizes internal development and support, ensuring high stability, security, and responsiveness to customer needs. With a rapidly growing customer base and a strong focus on integration with institutional financial and identity management systems, iLab is positioned as a reliable partner for research institutions seeking efficient management solutions.
LaserGen
Series B in 2016
LaserGen, Inc. is a biotechnology company based in Houston, Texas, established in 2002. The company specializes in the development and commercialization of advanced technologies for genomics applications, particularly in next-generation sequencing and histology. LaserGen's solutions include nucleotides and tools that facilitate the detection of heritable and somatic sequence variations in the human genome, which are essential for diagnostic purposes in disease management. By providing innovative and cost-effective sequencing platforms, LaserGen enables scientists to enhance their capabilities in nucleotide chemistry and genomics. As of May 2018, LaserGen operates as a subsidiary of Agilent Technologies, Inc.
Seahorse Bioscience
Acquisition in 2015
Seahorse Bioscience specializes in providing analytical instruments, biomanufacturing systems, and consumable labware for biological research and drug discovery. The company is known for its Seahorse extracellular flux (XF) analyzers, which allow for non-invasive profiling of cellular metabolic activity. These instruments enable researchers to assess key metabolic parameters, such as basal oxygen consumption, glycolysis rates, ATP turnover, and respiratory capacity, thereby facilitating the study of mitochondrial dysfunction. Seahorse Bioscience serves a diverse clientele, including scientists at academic institutions, pharmaceutical and biotech companies, and original equipment manufacturers of assay kits and laboratory instruments.
Cartagenia
Acquisition in 2015
Cartagenia is a provider of software and services designed for clinical genetics and molecular pathology laboratories. The company offers a specialized software platform that facilitates the assessment and reporting of clinical genomics data derived from next-generation sequencing and microarrays. This platform enables technicians, lab directors, and clinicians to visualize and evaluate genetic variants in the context of patient information, thereby streamlining the process of conducting clinically relevant genetic analyses. By delivering expert systems and services, Cartagenia supports genetic labs and healthcare professionals in providing high-quality genetic interpretation and counseling to patients and their caregivers.
Gradient Design Automation
Acquisition in 2014
Gradient Design Automation, Inc. specializes in electro-thermal analysis software designed to create three-dimensional temperature maps for integrated circuits (ICs) and system-in-package (SiP) designs. Founded in 2003 and headquartered in Santa Clara, California, the company offers several key products, including FireBolt, an electro-thermal simulator for digital integrated circuits; CircuitFire, targeted at analog and mixed-signal integrated circuits; and HeatWave, a transient electro-thermal simulator for similar applications. These tools assist in thermal analysis and sign-off, as well as in thermal validation during various design phases such as floorplanning, physical design, and package integration. Gradient Design Automation primarily serves IC designers and mixed-signal integrated device manufacturers in the United States, addressing critical challenges related to temperature and power in advanced nanometer scale designs.
Gen9
Private Equity Round in 2013
Gen9 is a privately held company based in Cambridge, Massachusetts, that specializes in next-generation gene synthesis technology. Founded in 2009 by leading experts in synthetic biology, Gen9 focuses on automating the production of DNA constructs with high throughput, accuracy, and cost-effectiveness. The company's innovations significantly enhance the capacity for DNA content production, enabling advancements in various industries, including pharmaceuticals, enzyme and chemical production, and biofuels. Through its scalable fabrication capabilities, Gen9 aims to promote the constructive application of synthetic biology, ultimately contributing to the improvement of genes, pathways, genomes, and organisms.
Aurora SFC Systems
Acquisition in 2012
Aurora SFC Systems, Inc. specializes in the development and manufacturing of supercritical fluid chromatography (SFC) products designed for laboratory environments. The company is recognized for offering innovative solutions, including the Agilent 1260 Infinity Analytical SFC system, which is a modular setup that integrates the Agilent 1260 Analytical SFC LC and the Aurora SFC Fusion A5 Evolution for the effective pre- and post-conditioning of carbon dioxide. By leveraging supercritical fluid chromatography technology, Aurora SFC Systems provides laboratory chemists with a cost-effective alternative to traditional high-performance liquid chromatography (HPLC) methods. The company's products are utilized both domestically in the United States and internationally, serving a diverse range of scientific applications.
Dako Denmark
Acquisition in 2012
Dako Denmark A/S specializes in providing reagents, instruments, and software for cancer diagnostics, primarily serving hospital and research laboratories globally. The company offers a wide range of pathology products, including antibodies, pharmacodiagnostic kits, and specialized staining instruments. These tools are essential for pathologists conducting in vitro diagnostics to identify cancer and other chronic diseases through tissue samples. Additionally, Dako produces flow cytometry products, which assist in analyzing cells in blood and other fluids for diagnosing conditions such as leukemia and lymphoma. The company also develops antibodies used to measure protein concentrations in various bodily fluids. Established in 1966 and headquartered in Glostrup, Denmark, Dako has formed collaborations with companies like Genentech and Roche for the clinical development of diagnostic tests. In 2012, Dako was acquired by Agilent Technologies.
Biosystem Development
Acquisition in 2011
BioSystem Development specializes in creating, manufacturing, and marketing system products aimed at addressing unmet needs in biotechnology and life science research. The company's innovative offerings include cartridges filled with small polymer beads, which facilitate rapid protein analysis for drug developers. By focusing on these specific applications, BioSystem Development supports advancements in research and enhances the efficiency of biotechnological processes.
Halo Genomics
Acquisition in 2011
A description for Halo Genomics is coming soon.
Accelicon Technologies
Acquisition in 2011
Accelicon Technologies is a privately held company specializing in the development of device-level modeling and validation software for the electronics industry. The company offers a SPICE model analysis solution designed for model quality assurance, facilitating a verification platform that connects fabrication and design processes. This solution enables the comparison, documentation, and validation of models provided by foundries. Additionally, Accelicon provides a modeling platform that assists modeling engineers in optimizing SPICE model libraries to accurately reflect silicon data and meet specific design requirements. Through its innovative software solutions, Accelicon plays a critical role in enhancing the efficiency and reliability of electronic circuit design and validation.
Lab901
Acquisition in 2011
Lab901 Limited engages in the development and production of automated gel electrophories in the United Kingdom. It offers ScreenTape P200 variant, which allows scientists in expressing and purifying recombinant proteins and monoclonal antibodies to carry out SDS-PAGE and analysis; ScreenTape R6K that is developed for reproducible RNA characterisation and quality control; and ScreenTape D800, which separates DNA fragments.
BIOCIUS Life Sciences
Acquisition in 2011
Biocius Life Sciences, Inc. is a company specializing in drug discovery research, established in 2009 and located in Woburn, Massachusetts. As a subsidiary of BioTrove, Inc., Biocius develops advanced technologies, including high-throughput mass spectrometry systems, to facilitate the drug discovery process. The company's innovative approach aims to enhance efficiency and accuracy in identifying potential therapeutic compounds, contributing to advancements in pharmaceutical research and development.
Novelx
Acquisition in 2010
Novelx, established in 2002 and located in Lafayette, California, specializes in the manufacturing of low-cost, high-resolution electron beam columns. The company utilizes miniaturized modular scanning electron microscope technology to produce these columns, which are designed for a variety of applications, including commercial use, inspection, analysis, lithography, and military purposes. By focusing on innovative solutions in electron beam technology, Novelx aims to meet the growing demands of industries that require precision and efficiency in their imaging and processing tasks.
Varian
Acquisition in 2009
Varian, Inc. is a prominent global supplier of scientific instruments and vacuum technologies, primarily catering to life science and industrial applications. The company offers a comprehensive range of products and services, including instruments, vacuum products, laboratory consumable supplies, software, and training, supported by an extensive global distribution network. Varian employs approximately 3,900 individuals and maintains manufacturing facilities across North America, Europe, and Asia Pacific. Through its diverse offerings, Varian plays a critical role in advancing research and development in various scientific fields.
MTS Nano Instruments
Acquisition in 2008
MTS Nano Instruments develops and supplies specialized equipment and software designed to measure the mechanical properties of nano-scale materials and structures. The company's product portfolio includes nano-indentation systems, nanomechanical testing systems, and quantitative imaging systems. Additionally, they offer software solutions such as TestWorks Professional for nanomechanical testing, TestWorks Explorer for test method design, TestWorks 3D for automated scanning processes, Virtual Indenter for finite-element simulations of indentation experiments, and Analyst for data analysis. MTS Nano Instruments also provides contract and educational services. Their products are utilized in verifying the structural integrity of semiconductor devices, coatings, and thin films, serving academic and industrial researchers in materials sciences, semiconductors, and life sciences. The company was founded in 1983 and is headquartered in Oak Ridge, Tennessee.
RVM Scientific
Acquisition in 2008
RVM Scientific, Inc. manufactures direct heating/cooling systems for gas chromatography capillary columns. The company’s products include low thermal mass retrofits and thermal desorber tubes. It also offers custom gas chromatography modules, which are used for low power consumption applications for portable instruments; high speed separations that use short narrow-bore columns; and column modules with metal columns that are used for high temperature applications.
Escort Instruments
Acquisition in 2008
Escort Instruments Corporation specializes in the manufacture of test and measurement instruments, catering to a variety of industries. The company offers a range of products, including general-purpose test instruments, process test tools, and automotive diagnostic tools. Designed for ease of transport, these measurement instruments facilitate installation and maintenance activities. Escort Instruments distributes its products through a global network of distributors, ensuring accessibility to its advanced testing solutions across diverse markets.
TILL Photonics
Acquisition in 2008
TILL provides extremely flexible, modular systems for all current and future microscopy standards – and complete turnkey solutions for imaging and photometry systems. The majority of TILL’s customers are found in the fields of neurobiology, cell biology, biomedicine and pharmacology. The company’s headquarters are located in the Munich BioRegio (Germany), TILL Photonics’ US operation is based in Rochester, NY
Velocity11
Acquisition in 2007
Velocity11 is a life sciences technology company that specializes in designing and manufacturing automation solutions for researchers in the life sciences sector. Founded in 1999 by Travis Chow and headquartered in the United States, the company offers a range of instruments, including liquid handling and microplate management products. Among its key offerings is BioCel, a robust sample processing platform that facilitates the assembly of genomics reactions, sample dispensing for compound preparation, and the processing of biological samples in screening applications. Velocity11 focuses on automation services tailored to drug discovery, genomics, and proteomics, enhancing the efficiency and effectiveness of scientific research.
Kalabie
Acquisition in 2007
Kalabie is a provider of Electronic Lab Notebook (ELN) software, established in 2000. The company initially focused on the pharmaceutical and medicinal chemistry markets, becoming a key player in the growing ELN sector. With funding from the Klee Group, Kalabie gained traction in Europe, particularly building a strong relationship with Sanofi-Aventis. By 2004, Kalabie experienced steady growth, enhancing its global presence and reputation as a leading solutions provider in laboratory informatics. The company offers R&D software services that facilitate knowledge and process management, ensuring high traceability of data from experimental work, which supports intellectual property protection in laboratories. In 2007, Kalabie was acquired by Agilent Technologies Inc., further integrating its innovative solutions into a broader portfolio of lab informatics services for the pharmaceutical and dermo-cosmetic industries.
Stratagene
Acquisition in 2007
Stratagene Corporation develops, manufactures, and markets life science research products in the United States and internationally. The company supports advances in science by inventing, manufacturing, and distributing products that simplify, accelerate, and improve research. Its products are used in the academic, industrial, and government research sectors in fields spanning molecular biology, genomics, proteomics, drug discovery, and toxicology.
PXIT
Acquisition in 2006
PXIT, Inc. develops and manufactures test and measurement systems, primarily for use in high-speed data communications. It also offers signal integrity testing solutions for broadband electro-optical signals. The company’s products include digital communications analyser, bit error rate tester, pattern generator, and synthesizer. It offers its products to telecommunications, data communications, and lighting markets.
Acqiris
Acquisition in 2006
Acqiris SA is a private company specializing in high-speed data acquisition solutions. It develops and manufactures digitizers and analyzers, renowned for their high sampling rates, precise signal capture, and real-time processing capabilities. These products cater to diverse industries such as mass spectrometry, medical imaging, and non-destructive testing, empowering researchers and engineers to gather high-quality data for analysis, experimentation, and product development.
Xpedion Design Systems
Acquisition in 2006
Xpedion Design Systems, Inc. specializes in providing advanced transistor-level simulation, analysis, and behavioral modeling solutions tailored for designers of radio frequency integrated circuits and system-on-chip applications. The company focuses on enhancing the design processes for wireless technology, enabling more efficient and effective development of complex electronic systems. Through its innovative tools, Xpedion supports engineers in optimizing their designs, ensuring high performance and reliability in the competitive landscape of integrated circuit design.
SynPro
Acquisition in 2006
SynPro Corp. manufactures short synthetic DNA and RNA molecules for the pharmaceutical and biotech industries. Its products are used as components of drugs in clinical trials. It makes synthetic nucleic acids used in biotech research.
Molecular Imaging Corp.
Acquisition in 2005
Molecular Imaging Corp. specializes in the development and manufacturing of nanotechnology measurement tools. The company produces a range of instruments, including Scanning Probe Microscopy and Atomic Force Microscopy systems, along with their associated accessories, software, and data management solutions. These tools are designed for imaging under controlled temperature and environmental conditions, making them suitable for various research applications. Molecular Imaging Corp. focuses on areas such as life science, biotechnology, electrochemistry, and material and polymer science. By providing advanced nanotechnology measurement solutions, the company enables customers to explore new application areas in both academic and industrial research settings.
Computational Biology
Acquisition in 2005
Computational Biology Corp. develops microarray-based techniques for understanding gene regulation in disease. The company utilizes ChIP-on-chip technology, which uses chromatin immuno-precipitation (ChIP) to discover how regulatory proteins interact with the genome of living cells.
Silicon Genetics
Acquisition in 2004
Silicon Genetics is a provider of software solutions tailored for the life sciences industry, emphasizing data analysis and management in molecular biology, statistics, and information technology. The company offers several key products, including GeneSpring, a desktop application that visualizes and analyzes genomic expression data; Varia, a genetic analysis software designed for life science researchers; and GeNet, a scalable repository for expression data. Through these offerings, Silicon Genetics supports researchers in their efforts to analyze complex biological data effectively.
Sirific Wireless
Series B in 2004
Sirific Wireless is a semiconductor company specializing in the design and development of CMOS RF transceivers for the wireless communications market. Founded in 2000, the company is headquartered in Richardson, Texas, with additional offices in Waterloo, Canada, and Seoul, Korea. Sirific Wireless offers a range of products, including monolithic multi-mode wireless designs, digital direct conversion products, Harmony direct upconversion transmitters, and its NEXUS platform. The NEXUS platform integrates various technologies such as HSDPA, WCDMA, EDGE, GPRS, and GSM, featuring on-chip receive diversity to create transceivers suitable for multi-mode and multi-band wireless applications.
TelASIC Communications
Series C in 2003
TelASIC Communications, Inc. develops remote radio head products for WCDMA/HSDPA and WiMAX/LTE infrastructure applications. The company's products enable the transmission of high output power to deliver high data rates and coverage for mobile TV/video/audio/data-centric 3G data services. TelASIC Communications, Inc. was founded in 2001 and is based in El Segundo, California.
RedSwitch
Acquisition in 2002
RedSwitch is a supplier of high performance switch fabric silicon solutions for the storage, server, networking, and telecom markets. Incorporated in June 2000 with headquarters in Milpitas, Calif., the company was formed by senior executives and design professionals from HAL Computer Systems Inc. RedSwitch products support leading interconnect standards including InfiniBand(TM), RapidIO (TM), and PCI-Express(TM).
SAN Valley Systems
Series C in 2002
SAN Valley is a privately held Silicon Valley company whose mission is to deliver high reliability, cost effective, next generation storage infrastructure solutions to enterprise and service providers worldwide. SAN Valley is developing high performance end-to-end optical edge access products to address the multi-billion dollar market opportunity for delivering value-added storage connectivity into enterprise, service provider and carrier networks.
Big Bear Networks
Series B in 2002
Big Bear Networks develops optical transponders and subassemblies for network operators.
Qosnetics
Acquisition in 2002
Qosnetics develops IP-based conformance verification and performance-stressing tools.
Tropian
Series D in 2001
Tropian, Inc. develops and provides multimode radio frequency integrated circuits and solutions for wireless devices. The company offers Timestar radio frequency integrated circuit solutions for quad-band cellular handsets; Codestar radio transceivers; and Multistar transceivers. It serves wireless device manufacturers. Tropian, Inc. was formerly known as Premier R.F., Inc.
WaveFront Research
Acquisition in 2001
WaveFront Research, Inc. specializes in the development of innovative optical systems and technologies designed to address complex challenges beyond the capabilities of conventional solutions. The company offers a range of products, including low-loss optical switches, compact optical time delay systems, and dense alignment-tolerant VCSEL-based optical interconnects for intra-board and board-to-board applications. Additionally, WaveFront Research excels in creating ultra-lightweight and compact hyperspectral imagers. To support its advanced research and development efforts, the company operates a sophisticated facility that features optical, mechanical, and electronics laboratories, a clean room, as well as specialized areas for machining, prototyping, and assembly. Its expertise caters to diverse sectors, including government, military, and commercial clients, positioning WaveFront Research as a leader in optical imaging technologies.
Novera Optics
Venture Round in 2001
Novera Optics specializes in the development of optical access solutions aimed at enhancing fiber-optic technology for last-mile networks. The company provides Passive Optical Network (PON) solutions that support fiber-to-the-building and fiber-to-the-curb applications, as well as services for multi-dwelling and multi-tenant units. Novera Optics also offers Wavelength Division Multiplexed-Passive Optical Networks (WDM-PON), which serve as an access and transport platform that facilitates the delivery of voice, data, video, and wireless services. By extending high-speed carrier Ethernet services from optical core networks to customer premises, Novera Optics enables equipment vendors and service providers to effectively address various market needs with a streamlined product offering.
Agilent's Interoperability Certification Labs
Acquisition in 2001
Agilent's Interoperability Certification Labs, Inc. provides third party product testing services. It specializes in test and analysis services, such as performance; benchmarking; interoperability; and functional, certification, and conformance testing. The company offers its services to original equipment manufacturers, systems integrators, and industry groups.
MV Technology
Acquisition in 2001
MV Technology Ltd. provides automated optical-inspection systems and solutions for the electronics-manufacturing market.
ATN Microwave
Acquisition in 2000
ATN Microwave is a manufacturer and designer focused on providing microwave measurement solutions for wireless and high-speed data communication applications. The company offers a range of products, including load pull, noise parameter, and S-parameter measurement tools. These products are essential for the RF, microwave, and high-speed digital sectors, enabling users to enhance signal integrity while ensuring power, accuracy, and stability in their communication components. Through its innovative solutions, ATN Microwave supports the development of advanced communication technologies.
Objective Systems Integrators
Acquisition in 2000
Objective Systems Integrators (OSI) is a global leader in Operations Support Systems (OSS) solutions tailored for communications service providers. Established in 1989, the company offers its flagship NetExpert® platform, which enables visibility and service assurance for major service providers, including those in next-generation services like LTE. OSI specializes in systems integration, software development, technology solutions, and IT consulting services, allowing organizations to optimize their technology investments and meet strategic goals. The NetExpert® platform is utilized by prominent communications service providers—encompassing fixed, broadband, and wireless sectors—to effectively manage networks, services, products, and customer relationships. It delivers comprehensive service, performance, and fault management for complex networks, providing detailed visibility into service quality at both aggregate and individual customer levels. With a global presence supported by sales offices and local partners, OSI has solidified its reputation for innovation in product and service offerings.
Entridia
Series C in 2000
Entridia Corporation is an Internet infrastructure company focused on developing advanced silicon and system solutions aimed at enhancing the convergence of data, voice, and video communications over the Internet. By providing innovative silicon-based routing engines, Entridia empowers original equipment manufacturers (OEMs) of router systems to create the next generation of Internet gateways. The company's products are designed to improve network connectivity, ensuring reliable and efficient communication across diverse platforms. Through its pioneering technology, Entridia plays a crucial role in shaping the future of Internet communications.
SAN Valley Systems
Series B in 2000
SAN Valley is a privately held Silicon Valley company whose mission is to deliver high reliability, cost effective, next generation storage infrastructure solutions to enterprise and service providers worldwide. SAN Valley is developing high performance end-to-end optical edge access products to address the multi-billion dollar market opportunity for delivering value-added storage connectivity into enterprise, service provider and carrier networks.
Zymed
Acquisition in 2000
Zymed, Inc. develops and markets inpatient telemetry systems, cardiac analysis software algorithms, and outpatient holter and cardiac event monitoring systems. It serves diagnostic monitoring markets, which include holter, telemetry, event recorder, home cardiac monitoring, intensive/coronary care units, prevention analysis, interventional cardiology, and arrhythmia and ischemia disease management.
American Holographic
Acquisition in 2000
American Holographic Inc is a company that specializes in the design and manufacture of holographic diffraction gratings and spectral sensor modules. Its products play a crucial role in various applications, including fiber optic communications, optical test equipment, pulse compression, and spectrographs. Additionally, the company's components are utilized in diverse industrial, research, and scientific contexts. By focusing on advanced optical technologies, American Holographic contributes significantly to fields that require precise measurement and analysis.
J&W Scientific
Acquisition in 2000
J&W Scientific, Inc. manufactures scientific instruments such as high resolution gas chromatography columns, flowmeters, syringes, and gas flow and control instruments. The company produces Unimetrics Syringes, Humonics Flowmeters and R&D Separations Gas Filters.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.